Amniotic fluid insulin concentration as a predictor of obesity

B E Metzger1, B L Silverman, N Freinkel

  • 1Center for Endocrinology, Metabolism, and Nutrition, Northwestern University Medical School, Chicago, Illinois 60611-3008.

Insights

High amniotic fluid insulin in diabetic pregnancies may predict childhood obesity. Intrauterine insulin exposure is linked to relative obesity in children by age 6, suggesting a predisposition to weight gain.

Area of Science:

  • Endocrinology
  • Pediatric Obesity
  • Prenatal Metabolism

Background:

  • Maternal diabetes can impact fetal development.
  • Intrauterine metabolic environment may influence long-term health outcomes.
  • Childhood obesity is a significant public health concern.

Purpose of the Study:

  • To investigate the correlation between prenatal amniotic fluid insulin levels and childhood anthropometrics.
  • To determine if intrauterine insulin exposure predicts later obesity in children of diabetic mothers.

Main Methods:

  • Longitudinal study of 56 children born to diabetic mothers.
  • Measured amniotic fluid insulin concentration between 32-38 weeks' gestation.
  • Assessed anthropometric characteristics (relative obesity) at 6 years of age, adjusting for maternal factors.

Main Results:

  • Higher amniotic fluid insulin correlated with increased relative obesity at age 6.
  • This association remained significant after adjusting for maternal obesity and birth macrosomia.
  • Children with the highest prenatal insulin exposure showed the greatest weight gain relative to height.

Conclusions:

  • Prenatal exposure to high insulin levels may predispose children to childhood obesity.
  • Amniotic fluid insulin concentration can serve as a predictor of future obesity.
  • Intrauterine metabolism plays a role in long-term anthropometric development.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...